Bristol-Myers Squibb CompanyBMYNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-1.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -68.72% |
| Q3 2025 | 61.12% |
| Q2 2025 | 100.46% |
| Q1 2025 | -55.98% |
| Q4 2024 | -20.60% |
| Q3 2024 | 140.37% |
| Q2 2024 | -17.93% |
| Q1 2024 | -33.35% |
| Q4 2023 | -10.50% |
| Q3 2023 | 151.78% |
| Q2 2023 | -36.46% |
| Q1 2023 | -10.16% |
| Q4 2022 | -10.33% |
| Q3 2022 | 63.07% |
| Q2 2022 | -40.69% |
| Q1 2022 | -6.04% |
| Q4 2021 | -22.96% |
| Q3 2021 | 72.09% |
| Q2 2021 | -19.98% |
| Q1 2021 | 4.20% |
| Q4 2020 | 61.89% |
| Q3 2020 | -49.54% |
| Q2 2020 | 14.12% |
| Q1 2020 | 93.18% |
| Q4 2019 | -20.27% |
| Q3 2019 | 22.71% |
| Q2 2019 | 49.86% |
| Q1 2019 | -42.77% |
| Q4 2018 | 89.91% |
| Q3 2018 | 21.00% |
| Q2 2018 | -10.04% |
| Q1 2018 | 5.19% |
| Q4 2017 | -34.79% |
| Q3 2017 | 8.14% |
| Q2 2017 | 83.97% |
| Q1 2017 | -39.71% |
| Q4 2016 | 1.71% |
| Q3 2016 | 219.82% |
| Q2 2016 | 292.54% |
| Q1 2016 | -137.32% |